These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 723979)

  • 21. [At the 40th anniversary of Society for Dutch Hospital Pharmacists].
    Winters JH
    Pharm Weekbl; 1969 Dec; 104(50):1569-70. PubMed ID: 4903017
    [No Abstract]   [Full Text] [Related]  

  • 22. The formulary system revisited.
    Lantos RL
    Hosp Formul; 1979 Jun; 14(6):664, 662. PubMed ID: 10297481
    [No Abstract]   [Full Text] [Related]  

  • 23. [On sense and nonsense of the use of eardrops as a therapeutic agent].
    Kindler W
    Dtsch Med Wochenschr; 1966 Aug; 91(32):1416-8. PubMed ID: 5926021
    [No Abstract]   [Full Text] [Related]  

  • 24. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of the Center for the Advancement of Pharmaceutical Education Educational outcomes, revised version 2004: report of the 2005 American College of Clinical Pharmacy Educational Affairs Committee.
    Bruce SP; Bower A; Hak E; Schwartz AH;
    Am J Pharm Educ; 2006 Aug; 70(4):79. PubMed ID: 17136198
    [No Abstract]   [Full Text] [Related]  

  • 26. ASHP guidelines on formulary system management.
    Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948
    [No Abstract]   [Full Text] [Related]  

  • 27. Utilization of the Center for the Advancement of Pharmaceutical Education Educational Outcomes, revised version 2004: report of the 2005 American College of Clinical Pharmacy Educational Affairs Committee.
    ; Bruce SP; Bower A; Hak E; Schwartz AH
    Pharmacotherapy; 2006 Aug; 26(8):1193-200. PubMed ID: 16863498
    [No Abstract]   [Full Text] [Related]  

  • 28. [THE ROYAL NETHERLANDS SOCIETY FOR THE ADVANCEMENT OF PHARMACY].
    WINTERS JM
    Tijdschr Soc Geneeskd; 1964 Jan; 42():16-8. PubMed ID: 14137272
    [No Abstract]   [Full Text] [Related]  

  • 29. Developing Drug Reports for the Pharmacy and Therapeutics Committee.
    Longe RL; Riley MW
    Am J Hosp Pharm; 1976 Jul; 33(7):651-2. PubMed ID: 941920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 32. [Summary of the practice guideline 'Otitis externa' (first revision) from the Dutch College of General Practitioners].
    Wiersma TJ; Rooijackers-Lemmens E; van Balen FA; Opstelten W; Starreveld JS; Goudswaard AN;
    Ned Tijdschr Geneeskd; 2008 May; 152(21):1210-4. PubMed ID: 18578449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 34. Policy committee work challenges members.
    Am Pharm; 1989 Jan; NS29(1):8. PubMed ID: 2923044
    [No Abstract]   [Full Text] [Related]  

  • 35. The P & T Committee Part 2: involvement by pharmacy, medical, and nursing personnel.
    Bender FH
    Hosp Formul; 1983 Jul; 18(7):692-6. PubMed ID: 10260988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASHP technical assistance bulletin on assessing cost-containment strategies for institutional pharmacies.
    Am J Hosp Pharm; 1985 Jul; 42(7):1583-91. PubMed ID: 4025363
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacy and Therapeutics committee. Cost-containment considerations.
    Hochla PK; Tuason VB
    Arch Intern Med; 1992 Sep; 152(9):1773-5. PubMed ID: 1520043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASHP technical assistance bulletin on assessing cost-containment strategies for pharmacies in organized health-care settings.
    Am J Hosp Pharm; 1992 Jan; 49(1):155-60. PubMed ID: 1570860
    [No Abstract]   [Full Text] [Related]  

  • 39. Summary of petition requesting recognition of clinical pharmacy as a specialty. Committee on Clinical Pharmacy as a Specialty.
    Am J Hosp Pharm; 1986 May; 43(5):1267-77. PubMed ID: 3717182
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacy service: what are the goals of the pharmacy and therapeutics committee?
    Francke DE
    Hospitals; 1967 Oct; 41(20):99-100 passim. PubMed ID: 6065407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.